Page last updated: 2024-08-26

wr 1065 and carboplatin

wr 1065 has been researched along with carboplatin in 5 studies

Research

Studies (5)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	3 (60.00)	18.2507
2000's	2 (40.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Holwerda, U; Klein, I; Pinedo, HM; Treskes, M; van der Vijgh, WJ	1
Berens, ME; Dougherty, DV; Doz, F; Rosenblum, ML; Spencer, DR	1
Eeltink, CM; Korst, AE; van der Vijgh, WJ; Vermorken, JB	1
Berthold, F; Fichtner, I; Fulda, S; Hero, B	1
Baruchel, S; Fouladi, M; Gammon, J; Grant, R; Greenberg, ML; Klein, J; Koren, G; Stempak, D	1

Trials

3 trial(s) available for wr 1065 and carboplatin

Article	Year
Pharmacokinetics of amifostine and its metabolites in patients. European journal of cancer (Oxford, England : 1990), 1997, Volume: 33, Issue:9 Topics: Adult; Amifostine; Antineoplastic Agents; Carboplatin; Cisplatin; Disulfides; Drug Therapy, Combination; Female; Half-Life; Humans; Male; Mercaptoethylamines; Middle Aged	1997
Preclinical and clinical aspects on the use of amifostine as chemoprotector in neuroblastoma patients. Medical and pediatric oncology, 2001, Volume: 36, Issue:1 Topics: Adolescent; Amifostine; Animals; Antineoplastic Agents; Bone Marrow Diseases; Carboplatin; Cell Division; Child; Child, Preschool; Cisplatin; Cross-Over Studies; Cyclophosphamide; Dose-Response Relationship, Drug; Doxorubicin; Drug Interactions; Etoposide; Humans; Ifosfamide; Mercaptoethylamines; Mice; Mice, Nude; Neuroblastoma; Neutropenia; Prodrugs; Safety; Thrombocytopenia; Treatment Failure; Tumor Cells, Cultured; Vincristine; Vomiting; Xenograft Model Antitumor Assays	2001
Phase I trial of a twice-daily regimen of amifostine with ifosfamide, carboplatin, and etoposide chemotherapy in children with refractory carcinoma. Cancer, 2001, Aug-15, Volume: 92, Issue:4 Topics: Adolescent; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Child; Child, Preschool; Drug Administration Schedule; Etoposide; Female; Humans; Ifosfamide; Male; Mercaptoethylamines; Neoplasms; Treatment Failure	2001

Other Studies

2 other study(ies) available for wr 1065 and carboplatin

Article	Year
The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin. Biochemical pharmacology, 1991, Nov-06, Volume: 42, Issue:11 Topics: Amifostine; Carboplatin; Cisplatin; Drug Administration Schedule; Drug Interactions; Kinetics; Mercaptoethylamines; Radiation-Protective Agents	1991
Experimental basis for increasing the therapeutic index of carboplatin in brain tumor therapy by pretreatment with WR compounds. Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:4 Topics: Bone Marrow; Bone Marrow Cells; Brain Neoplasms; Carboplatin; Cell Line; Cells, Cultured; Colony-Forming Units Assay; Drug Interactions; Drug Screening Assays, Antitumor; Glioma; Humans; Mercaptoethylamines; Tumor Cells, Cultured	1991

Article

Year

The chemical reactivity of the modulating agent WR2721 (ethiofos) and its main metabolites with the antitumor agents cisplatin and carboplatin.

Biochemical pharmacology, 1991, Nov-06, Volume: 42, Issue:11

Topics: Amifostine; Carboplatin; Cisplatin; Drug Administration Schedule; Drug Interactions; Kinetics; Mercaptoethylamines; Radiation-Protective Agents

1991

Experimental basis for increasing the therapeutic index of carboplatin in brain tumor therapy by pretreatment with WR compounds.

Cancer chemotherapy and pharmacology, 1991, Volume: 28, Issue:4

Topics: Bone Marrow; Bone Marrow Cells; Brain Neoplasms; Carboplatin; Cell Line; Cells, Cultured; Colony-Forming Units Assay; Drug Interactions; Drug Screening Assays, Antitumor; Glioma; Humans; Mercaptoethylamines; Tumor Cells, Cultured

1991